VAV expands cGMP Lecithins capacity

VAV Life Sciences Mumbai is expanding it's manufacturing capacity of pharmaceutical cGMP lecithins & phospholipids, within the 1st year of its commercial launch due to high demand from European customers. One of four such global producers, VAV is currently serving the markets of hepatoprotection & nootropic agents. The additional 100 tons per year capacity will support additional customers in North America. Lecithin & phospholipids have significant
demand due to their GRAS status and well-established safety.

“We are proud of the flawless commissioning of pharmaceutical grade lecithins & phospholipids at Ratnagiri and the commercial acceptance of its products within EU. The new unit increases our reach to new European customers and allows us to spread to North American & Russian markets. It strengthens growth of our innovative solutions for the healthcare industry,” said Vrushali Patil, Marketing Manager, VAV.

VAV is an innovation driven company specialize in making ‘Lecithins and Phospholipids’ with a focus to provide solutions in the fields of pharmaceutical ingredients, nutritional supplements and cosmeceuticals.

VAV Life Sciences Pvt Ltd
51/B Mittal Court,
Mumbai, India 400021

Vrushali Patil (vrushali@vav.in)

This release was published on openPR.